Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Shares Down 21.5%

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) dropped 21.5% on Thursday . The company traded as low as $220.77 and last traded at $227.78. Approximately 41 shares changed hands during trading, a decline of 65% from the average daily volume of 116 shares. The stock had previously closed at $290.00.

Sartorius Aktiengesellschaft Stock Performance

The company has a debt-to-equity ratio of 1.82, a quick ratio of 0.69 and a current ratio of 1.47. The company has a market capitalization of $7.80 billion, a P/E ratio of 70.30 and a beta of 0.93. The firm has a 50 day moving average price of $293.34 and a two-hundred day moving average price of $271.94.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last issued its quarterly earnings data on Friday, February 16th. The company reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.31 by ($0.30). The firm had revenue of $915.06 million for the quarter, compared to the consensus estimate of $900.00 million. Sartorius Aktiengesellschaft had a return on equity of 12.44% and a net margin of 6.04%. On average, research analysts expect that Sartorius Aktiengesellschaft will post 5.98 earnings per share for the current fiscal year.

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.